SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-051798
Filing Date
2013-02-12
Accepted
2013-02-12 16:31:05
Documents
3
Period of Report
2013-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d482941d8k.htm 8-K 21446
2 EX-99.1 d482941dex991.htm EX-99.1 8450
3 GRAPHIC g482941g25g93.jpg GRAPHIC 8744
  Complete submission text file 0001193125-13-051798.txt   43293
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 13597599
SIC: 2834 Pharmaceutical Preparations